openPR Logo
Press release

Artificial Joints and Reconstruction Devices Market Demand And Trends Till 2020

01-19-2017 05:06 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: SA-BRC

Artificial Joints and Reconstruction Devices Market Demand

Joint diseases and conditions mostly result in the degradation of cartilage and fluid between bones that is necessary for smooth, painless and quick movement of joints. Degenerative joint diseases such as osteoarthritis or gout along with stress related conditions that result in damage to the joints require arthroplasty. Arthroplasty is the surgical repair to improve movement between the two ends of bones at a joint. The procedure can be performed on most large joints such as shoulders, knees and hips conveniently. Having a bad joint can become extremely painful for many people and hinders with their daily activity on a great level. In creating more effective knee implants, scientists must ensure that synthetic knee components can withstand joint wear, kinetic impact, biocompatibility and antibacterial properties. In the past amputation was preferred over surgical repair as these devices were unavailable.

Post 1950, people had options to have artificial joints implanted for repair of joints even in knuckles, elbows and ankles. Most implant joints are made from sterile and non-reactive metals such as stainless steel, cobalt, titanium and zirconium which is the latest trend in the orthopaedic industry. Joints are also made from biomaterials and certain forms of plastic such as polyethylene. Around 500,000 knee replacements and 200,000 hip replacements take place each year across the globe. Due to the aging population which comprises the largest segment of patients with the implants, the market for artificial joints is expected to further expand in coming years. Although the market was hurt significantly in the last recession, it is now slowly gaining pace again. Reconstruction of joints involves damage repair to torn ligaments and tendons through the use of arthroscopic technologies. Reconstruction is heavily involved in sports medicine, where accidents and injuries can be severe and occur across all ages. Joints are also chosen for the age of the person to be implanted with the device. Total uncemented joints are typically used for the older generation where bone growth is very low. Total cemented joints use porous material that can act as a scaffold for growth of bone mass.

Free Sample Report@

Hemiarthroplasties are done for a partial replacement of affected joints. The procedure is also called joint resurfacing. With increasing number of accidents and trauma incidences rising, the market is now gaining pace again. Manufacturers have been facing several hurdles in terms of regulations and failures in technologies. Stryker recall of its Rejuvenate hip joints has decimated the company performance for 2012 and is expected to affect the company growth in 2013 as well. Johnson & Johnson DePuy Synthes and Zimmer have not been much better off, as both companies have been facing a salvo of legal battles in past few years on failed orthopaedic implants particularly for hip replacement.

The artificial joint replacement and reconstruction market is highly fragmented with over 20 market players spread across globally. The companies operate on highly competitive pricing strategies and cost of devices in emerging economies of Middle-East, Latin America and Asia-Pacific is less than a third of that in United States. This has led to a significant increase in medical tourism for orthopaedic procedures. Many factors such as obesity, diabetes, genetic disorders and increasing aging population over the world drive the market and it is also expected to gain from next generation total replacement joints for smaller extremity joints such as toes and fingers. DePuy Synthes, Stryker, Zimmer, Smith & Nephew, Biomet, Orthofix, Wright Medical and Arthrocare are key players in this largely fragmented market. Global estimates indicate that there may be over 200 companies with a large fraction local and regional device manufacturers particularly in Asia-Pacific and Latin America.

Click For Request TOC@

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
10685-B Hazelhurst Drive,
Suite 17411
Houston, Texas 77043,
United States
Phone: +1(832)-426-3701

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Artificial Joints and Reconstruction Devices Market Demand And Trends Till 2020 here

News-ID: 417344 • Views: 320

More Releases from SA-BRC

Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage. Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients. The

All 5 Releases

More Releases for Joint

MOFLON TECHNOLOGY Offers Rotary Joint Solutions
MOFLON TECHNOLOGY is a company whose focus is offering a range of high-quality pancake, waterproof, capsule, miniature, turbine, through bore, military grade, fiber optic rotary joint, hybrid, and customized slip rings among others to their clientele. The company manufactures these slip rings using sophisticated CNC machinery and excellent materials, and they warrant that they go through rigorous quality checks to ensure quality. Assurances MOFLON TECHNOLOGY offers clients who shop with
ALCOR's Joint Venture model : How it Works?
Entering a joint venture is a smart move to grow your company’s influence, reach new markets and diversify its products. But, starting your joint venture might be difficult without a structured plan, and your aspirations for joint venture could fall flat. ALCOR M&A helps you in identifying the right partner for your business, defining the goals and keeps you on track with the ongoing communication. Request Information: Finding the Right Partner When you
Joint Health Ingredients: Global Market Intelligence
ReportsWorldwide has announced the addition of a new report title Joint Health Ingredients: Global Market Intelligence to its growing collection of premium market research reports. The report “Joint Health Ingredients: Global Market Intelligence” provides market intelligence on the different market segments, based on type, application, and geography. Market size and forecast (2011-2020) has been provided in the report. The primary objectives of this report are to provide 1) comprehensive global market intelligence through
Joint Press Release announcing SweeterSync
Diligent launches SweeterSync, an Exchange-Server software for SuiteCRM. Diligent Technology & Business Consulting is an international software consultancy firm with headquarters in Frankfurt and Budapest. They have taken their combined 80 years experience and created a server side synchronisation between SuiteCRM and Microsoft Exchange-Server called SweeterSync. It has been designed with simplicity in mind and so it requires the minimum of effort to operate and doesn’t need any installation on the
Joint “attack” on the camshaft
For example in China – even if the automobile market in the country is currently growing more moderately, the “Middle Kingdom” is still the driving force on the global market. Around 11 million automobiles were produced in China in 2009 and the figure rose to around 14 million in 2010. In 2011, production growth slowed to about 15 million vehicles (source: PwC, Statista). Imports of automobile components, complete engines and
Joint Health Supplement
Salt Lake City, Utah (July 19, 2011) – ENovate Biolife LLC, announced the launch of its clinically documented supplement for joint health ‘Lanconone’. Lanconone is popular worldwide and is now available online in the US. Lanconone is an all natural formula tested to deliver greater joint flexibility and facilitate walking, bending, climbing, gardening and other everyday activities. Lanconone is manufactured under Gold standards using standardized ingredients to give fast and